Skip to content

Evaluation of the effect of vitamin E in women with urinary tract infection

Evaluation of the effects of vitamin E on the treatment and prevention of relapse in women with lower urinary tract infection

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210617051604N1
Enrollment
80
Registered
2021-07-11
Start date
2021-07-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower urinary tract infection. Urinary tract infection, site not specified

Interventions

Intervention 1: Intervention group: Vitamin E softgel 100 units daily for 6 months. Intervention 2: Control group: Vitamin E softgel placebo 100 units daily for 6 months.

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women over 18 years At least three symptoms including frequency, urgency (urgent need to urinate), dysuria, hematuria, and suprapubic pain

Exclusion criteria

Exclusion criteria: History of allergy or intolerance to vitamin E Peptic ulcer bleeding Hemophilia Use of antiplatelet and anticoagulant drugs Urinary tract obstruction and urological abnormalities History of renal abscess Diabetes mellitus Taking antibiotics in the previous two days Catheterization two weeks ago History of hospitalization or catheter in two weeks ago Kidney stones Pregnancy and lactation Immune deficiency (Patients with HIV, etc) Vitamin K deficiency Liver and renal failure Candidate for surgery Flank pain, fever above 37.7 ° C, fever and chills, feeling ill and tired or other evidence of systemic infection, CVA tenderness, symptoms of vaginitis (itching and vaginal discharge)

Design outcomes

Primary

MeasureTime frame
Frequency. Timepoint: 3 to 5 days after starting treatment. Method of measurement: Questionnaire.;Dysuria. Timepoint: 3 to 5 days after starting treatment. Method of measurement: Questionnaire.;Urgency. Timepoint: 3 to 5 days after starting treatment. Method of measurement: Questionnaire.;Recurrence rate of urinary tract infection. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Questionnaire.;Mean recovery time. Timepoint: During study. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHajar Mafakher

Birjand University of Medical Sciences

hajar.mafakher738@gmail.com+98 56 3162 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026